A Microbiota-Dependent Response to Anticancer Treatment in an <i>In Vitro</i> Human Microbiota Model: A Pilot Study With Hydroxycarbamide and Daunorubicin.

Front Cell Infect Microbiol · 2022 · PMC9198576 · PMID 35719352

Europe PMC DOI

hedged sentence

0.0400

closest p · 0.8× alpha

0.0400

boldest claim

The sentences

marginally significantp = 0.04actually significant

The overall effect of treatment was not found to be significant for hydroxycarbamide ( p = 0.23) but was marginally significant for donor A ( p = 0.04).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.